- Posted June 06, 2014
- Tweet This | Share on Facebook
Michigan, 43 states settle with GlaxoSmithKline
LANSING (AP) - A multinational drugmaker is paying Michigan, 43 other states and the District of Columbia $105 million to settle complaints that the company unlawfully marketed three drugs.
Michigan Attorney General Bill Schuette announced Wednesday that Michigan's share of the settlement is $2.6 million. The settlement resolves allegations that London-based GlaxoSmithKline illegally marketed Advair, Paxil and Wellbutrin for purposes that hadn't been approved by the Food and Drug Administration.
GSK is prohibited from disseminating information that describes any so-called off-label use.
The asthma drug Advair is Glaxo's best-selling product. Paxil and Wellbutrin are antidepressants.
Published: Fri, Jun 06, 2014
headlines Oakland County
- Whitmer signs gun violence prevention legislation
- Department of Attorney General conducts statewide warrant sweep, arrests 9
- Adoptive families across Michigan recognized during Adoption Day and Month
- Reproductive Health Act signed into law
- Case study: Documentary highlights history of courts in the Eastern District
headlines National
- Oscar vs. Jeff: Trial lawyers and appellate counsel do different jobs, and it may show in their writing
- ‘Can a killer look like a granny?’ Prosecutor poses questions as mother-in-law of slain law prof goes on trial
- ILTACON 2025: The Wild, Wild West of legal tech
- After striking deal with Trump, this BigLaw firm worked with liberal groups to secure pro bono wins in 2 cases
- ‘Early decision conspiracy’ among top colleges is an antitrust violation, suit alleges
- Striking the Balance: How to make alternative fee arrangements work for everyone
